人福医药成立创新生物产业发展公司

Group 1 - A new company named Renfu Innovation Biopharmaceutical Development (Wuhan) Co., Ltd. has been established with a registered capital of 100 million yuan [1] - The legal representative of the new company is Li Xiaopei [1] - The business scope of the company includes drug production, entrusted drug production, drug wholesale, and internet information services related to pharmaceuticals [1] Group 2 - Renfu Innovation Biopharmaceutical Development is wholly owned by Renfu Pharmaceutical [1]